| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |